EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Bone morphogenetic protein signaling as a key regulator of retinal fibrosis

Sonali Sharma iD, Gieth Alahdab, Muhammad Nazmul Haque, Ikbal Karkoukli iD, Alee Assaf, Yuichiro Ishida iD, Ahmed Abu Elasrar, Mohamed Moustafa, Mohamed Tarek iD, Xiao Zhang, Kenneth P Mitton, Natasha Josifovska und 4 weitere

Proceedings of the National Academy of Sciences · 13.10.2026 · 123 (41)

DOI: 10.1073/pnas.2603111123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 07.10.2026. Verfasst von Sonali Sharma und 15 weiteren Autor:innen. Beteiligte Einrichtung: Eye Research Centre, Oakland University William Beaumont School of Medicine, Rochester, MI 48309. Hauptthemen laut MEDLINE: Signal Transduction, Retina, Bone Morphogenetic Protein 4, Bone Morphogenetic Protein 2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDCR NIH HHS, NEI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Retinal fibrosis is a blinding complication of proliferative diabetic retinopathy (PDR), proliferative vitreoretinopathy (PVR), age-related macular degeneration (AMD) and idiopathic epiretinal membrane (iERM), yet effective therapies remain lacking. The purpose of this study was to investigate the role of BMP2 and BMP4 (BMP2/4)–activin receptor-like kinase (ALK) signaling in retinal fibrosis. BMP2 was detected in the vitreous of PDR, PVR, and rhegmatogenous retinal detachment (RRD) samples at concentration of 70, 180, and 85 pg/mL respectively, whereas it was present only at trace levels or was undetectable in the vitreous of macular hole and idiopathic ERM samples (~0.1 pg/mL). PDR, PVR, and idiopathic ERMs exhibited strong immunoreactivity for BMP2, BMP4, ALK3 (Bmpr1a), pSMAD1/5/9, and pSMAD4. Formation of preretinal fibronectin-containing membranes resulted from intravitreal injection of wild-type mice with BMP2 and similar membranes formed in mice expressing constitutively active ALK3 (caBmpr1a). The presence of preretinal membrane in caBmpr1a was confirmed by optical coherence tomography. The limited hyperoxia-induced proliferative retinopathy (LIHPR) model demonstrated a progressive increase in the retinal expression of BMP2 and BMP4and development of preretinal membrane. Administration of BMP/ALK inhibitor LDN193189 induced regression of the preretinal membrane in LHIPR. BMP2 and BMP4 induced a significant increase in the expression of Glial Fibrillary Acidic Protein (GFAP), fibronectin, and collagen-VI in cultured rat Muller glial cells, and increased fibronectin was reversed by BMP/ALK inhibition. BMP2 also significantly upregulated fibronectin and activated matrix metalloproteinase-2 in human retinal endothelial cells. These findings support BMP2/4–ALK signaling as a potential mediator and therapeutic target in retinal fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Signal TransductionRetinaBone Morphogenetic Protein 4Bone Morphogenetic Protein 2AnimalsHumansMiceDiabetic RetinopathyFibrosisVitreoretinopathy, ProliferativeRatsEpendymoglial CellsVitreous BodyEpiretinal MembraneFibronectinsPyrimidinesBone Morphogenetic Protein Receptors, Type IActivin Receptors, Type II

Stichwörter der Autor:innen

bone morphogenetic proteinproliferative diabetic retinopathyproliferative vitreoretinopathyretinal endothelial cellsretinal fibrosis

Substanzen

Bone Morphogenetic Protein 4Bone Morphogenetic Protein 2FibronectinsPyrimidinesBone Morphogenetic Protein Receptors, Type IAcvrl1 protein, mouseActivin Receptors, Type II

Autor:innen und Institutionen

  • Eye Research Centre, Oakland University William Beaumont School of Medicine, Rochester, MI 48309.
  • Eye Research Institute, Oakland University, Rochester, MI 48309.
  • Department of Ophthalmology, King Saud University, Riyadh 11461, Saudi Arabia.
  • Center for Eye Research and Innovative Diagnostics, Department of Ophthalmology, Oslo University Hospital, Oslo 0450, Norway.
  • Department of Ophthalmology, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo 0450, Norway.
  • Department of Ophthalmology, Faculty of Medicine, University of Split, Split 21000, Croatia.

ORCID-Profile: Sonali Sharma, Ikbal Karkoukli, Yuichiro Ishida, Mohamed Tarek, Goran Petrovski, Yuji Mishina, Mohamed Al-Shabrawey

Förderung

  • NIDCR NIH HHS
  • NEI NIH HHS

Zitieren

APA

Sharma, S., Alahdab, G., Haque, M. N., Karkoukli, I., Assaf, A., Ishida, Y., Abu Elasrar, A., Moustafa, M., Tarek, M., Zhang, X., Mitton, K. P., Josifovska, N., Petrovski, G., Ueharu, H., Mishina, Y., & Al-Shabrawey, M. (2026). Bone morphogenetic protein signaling as a key regulator of retinal fibrosis. Proceedings of the National Academy of Sciences, 123(41). https://doi.org/10.1073/pnas.2603111123

Vancouver

Sharma S, Alahdab G, Haque MN, Karkoukli I, Assaf A, Ishida Y, et al. Bone morphogenetic protein signaling as a key regulator of retinal fibrosis. Proceedings of the National Academy of Sciences. 2026;123(41). doi:10.1073/pnas.2603111123

BibTeX
@article{Sharma2026,
  author = {Sharma, Sonali and Alahdab, Gieth and Haque, Muhammad Nazmul and Karkoukli, Ikbal and Assaf, Alee and Ishida, Yuichiro and Abu Elasrar, Ahmed and Moustafa, Mohamed and Tarek, Mohamed and Zhang, Xiao and Mitton, Kenneth P and Josifovska, Natasha and Petrovski, Goran and Ueharu, Hiroki and Mishina, Yuji and Al-Shabrawey, Mohamed},
  title = {Bone morphogenetic protein signaling as a key regulator of retinal fibrosis},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  volume = {123},
  number = {41},
  doi = {10.1073/pnas.2603111123}
}
Kostenlos starten →